6 completed, 1 unknown. 5 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Jejunostomy: new trials by email Literature Review of Jejunostomy trials Research Report on Jejunostomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump, PEG tube - Advanced Parkinson's Disease | Phase 3 | Completed | AbbVie | 31 | 2013-10-01 | 2018-05-30 |
| Early Jejunostomy Nutrition Minimizes Time to Chemotherapy Jejunostomy, Early oral nutrition - Gastric Cancer, Laparoscopic Surgery | Phase 4 | Unknown | Jinling Hospital, China | 100 | 2013-04-01 | 2013-01-11 |
| Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Levodopa carbidopa intestinal gel (LCIG), Placebo Gel, Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets - Advanced Parkinson's Disease | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 35 | 2009-12-01 | 2015-01-16 |
| Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump, PEG tube - Dyskinesias, Parkinson's Disease | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 62 | 2009-06-01 | 2015-01-16 |
| Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Levodopa carbidopa intestinal gel (LCIG), Placebo gel, Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets - Advanced Parkinson's Disease | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 36 | 2009-01-01 | 2015-01-16 |
| Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump, PEG tube - Advanced Parkinson's Disease | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 354 | 2008-01-01 | 2015-01-16 |
| Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact Levodopa-carbidopa intestinal gel (LCIG), CADD-Legacy® 1400 ambulatory infusion pump, percutaneous endoscopic gastrostomy tube (PEG tube) - Advanced Idiopathic Parkinson's Disease | Phase 4 | Completed | AbbVie (prior sponsor, Abbott) | 77 | 2006-03-01 | 2016-07-18 |
Dyskinesias (4) · Parkinson Disease (2) · Stomach Neoplasms (1)
AbbVie (prior sponsor, Abbott) (5) · AbbVie (1) · Jinling Hospital, China (1)
United States (4) · Germany (3) · New Zealand (3) · Australia (1) · Canada (1) · China (1) · Czechia (1) · Finland (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1) · Portugal (1) · Russia (1) · Spain (1)
Janet Benesh (4) · Lars Bergmann, MD (1) · Masayoshi Yanagawa, PhD (1) · Qi Mao, MD/PhD (1)
PMID 25962554, PMID 24361112, PMID 31779508, PMID 25545465, PMID 26777085, PMID 28725701
2005 (1)